Your search returned 2 results.

Results
	1.	Diroximel Fumarate Demonstrates an Improved Gastrointestinal Tolerability Profile Compared with Dimethyl Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Randomized, Double-Blind, Phase III EVOLVE-MS-2 Study. [electronic resource] by Naismith, Robert T Wundes, Annette Ziemssen, Tjalf Jasinska, Elzbieta Freedman, Mark S Lembo, Anthony J Selmaj, Krzysztof Bidollari, Ilda Chen, Hailu Hanna, Jerome Leigh-Pemberton, Richard Lopez-Bresnahan, Maria Lyons, Jennifer Miller, Catherine Rezendes, David Wolinsky, Jerry S Producer: 20210609 In: CNS drugs vol. 34 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Diroximel fumarate (DRF) in patients with relapsing-remitting multiple sclerosis: Interim safety and efficacy results from the phase 3 EVOLVE-MS-1 study. [electronic resource] by Naismith, Robert T Wolinsky, Jerry S Wundes, Annette LaGanke, Christopher Arnold, Douglas L Obradovic, Dragana Freedman, Mark S Gudesblatt, Mark Ziemssen, Tjalf Kandinov, Boris Bidollari, Ilda Lopez-Bresnahan, Maria Nangia, Narinder Rezendes, David Yang, Lili Chen, Hailu Liu, Shifang Hanna, Jerome Miller, Catherine Leigh-Pemberton, Richard Producer: 20210924 In: Multiple sclerosis (Houndmills, Basingstoke, England) vol. 26 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search